Company news
Acurx Pharmaceuticals, Inc. news in 2022
Acurx Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
November 13, 2022
Acurx Announces Scientific Oral and Poster Presented at IDWeek 2022
October 25, 2022
Acurx Announces Scientific Oral and Poster Presentations at IDWeek
October 16, 2022
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update
August 14, 2022
Acurx Announces New Data Presentations from Ongoing Ph2 Clinical Trial Program of Ibezapolstat for CDI at the 16th Biennial Congress of the Anaerobe Society of America
August 1, 2022
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
July 24, 2022
Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
May 10, 2022
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
March 16, 2022
Acurx Announces Publication of Positive Phase 2a Clinical Trial Results of Ibezapolstat for CDI in Clinical Infectious Diseases
February 6, 2022
Decks in 2022
- ID Week 2022
Conference · 17 slides · October 2022